Table 1.
Overview of the studies reporting on the prevalence of SARS-CoV-2 infection in dogs and cats with known COVID-19 positive human owners.
| Pet | Detection method | Sample type | Country | Study period | N total |
N positives |
Prevalence (%) | 95% confidence interval | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Cats | (N) xMAP | Serum | Italy | Mar’20-Jun’20 | 54 | 11 | 20.37 | 11.77 - 32.90⁎ | [38] |
| VNT | Serum | Italy | Mar’20-May’20 | 22 | 1 | 4.5 | 0.81 - 21.80⁎ | [21] | |
| Dogs | (N) xMAP | Serum | Italy | Mar’20-Jun’20 | 93 | 3 | 3.2 | 1.10 - 9.06⁎ | [38] |
| VNT | Serum | Italy | Mar’20-May’20 | 47 | 6 | 12.8 | 5.98 - 25.17⁎ | [21] |
⁎
Statistics not reported in the original studies and thus derived from available data using Wilson's method for proportions. VNT = Virus neutralization test. xMAP = Bead-based immunoassay. (N) = Nucleocapsid protein.